1994
DOI: 10.1111/j.1600-0749.1994.tb00074.x
|View full text |Cite
|
Sign up to set email alerts
|

The Role of 80K/MARCKS, a Specific Substrate of Protein Kinase C, in Cell Growth and Tumour Progression

Abstract: Since its discovery more than a decade ago [Wu et al., 1982; Rozengurt et al., 1983], the 80-87 kDa myristoylated alpha lanine-rich C-kinase substrate (80K/MARCKS) protein has attracted a great deal of attention from researchers interested in cell growth and tumour progression. However, despite its ubiquitous distribution, a definitive functional role for 80K/MARCKS has not been found. The purpose of this review is to describe the properties, distribution and regulation of 80K/MARCKS and to discuss some of the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
7
0

Year Published

1997
1997
2007
2007

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 39 publications
1
7
0
Order By: Relevance
“…Because MARCKS emerges as a growth and tumor suppressor gene [23,25], which is down‐regulated in many transformed cell types, it will be of interest to investigate the reasons for its low expression in malignant cells. It is possible that mutations in its 3′‐UTR prevent binding of factors like HuD/HuR which normally inhibit degradation of the transcript.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Because MARCKS emerges as a growth and tumor suppressor gene [23,25], which is down‐regulated in many transformed cell types, it will be of interest to investigate the reasons for its low expression in malignant cells. It is possible that mutations in its 3′‐UTR prevent binding of factors like HuD/HuR which normally inhibit degradation of the transcript.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, overexpression of the MARCKS protein in fibroblasts caused slow growth rate, a low final cell density and enhanced susceptibility towards calmodulin antagonists [24]. Additionally, the finding that many tumor cell lines have no or reduced MARCKS expression supports the hypothesis that MARCKS is a tumor and/or growth suppressor gene in some cell types [25–27]. The precise physiological role of this widely distributed PKC substrate has not been convincingly established yet (reviewed in [28–30].…”
mentioning
confidence: 99%
“…These include PKC-mediated regulation of local Ca 2+ -calmodulin levels (Blackshear 1993), binding and cross linking of F-actin filaments (Hartwig et al 1992), regulation of PIP 2 availability (Glaser et al 1996), and activation of phospholipase D (PLD) (Morash et al 1998). At the cellular and physiological levels, MARCKS and (or) MRP have been implicated in such diverse processes as regulation of integrin mobility underlying cell adhesion and migration (Zhou and Li 2000); neurosecretion (Trifaro et al 2002); membrane trafficking including exo-, endo-, and phagocytosis (Allen and Aderem 1995); tumor suppression (Brooks 1994); synaptic plasticity (Sheu et al 1993); and the pathophysiology of mood disorders (Manji and Lenox 1999). All of these functions can be directly or indirectly related to the PIP 2 binding properties of MARCKS and MRP, which in turn can be controlled coordinately by calmodulin, by PKC, and by altered gene expression.…”
Section: Introductionmentioning
confidence: 97%
“…There are three distinctive domains in MARCKS: a myristoylated N-terminal domain that mediates the binding of MARCKS to the plasma membrane, a highly conserved MARCKS homology domain (MH2 domain) of unknown function, and an extremely basic phosphorylation site domain (PSD) that contains PKC phosphorylation sites and sites for calmodulin and actin binding (6).…”
mentioning
confidence: 99%